Literature DB >> 1568401

New grading and scoring for anal incontinence. Evaluation of 335 patients.

M Pescatori1, G Anastasio, C Bottini, A Mentasti.   

Abstract

A grading system of anal incontinence (AI) is described that takes into account both degree and frequency of symptoms. A, B, and C indicate AI for flatus/mucus, liquid stool, and solid stool, respectively; 1, 2, and 3 indicate occasional, weekly, and daily AI. A scoring system, ranging from 0 (continence) to 6 (severe AI, i.e., daily AI for solid stool or C3) also is reported. Three hundred thirty-five patients have been evaluated by this method in our institution: 30 percent had severe AI, graded as C3; only 9 percent had mild symptoms graded as A. Both males and females could not control diarrhea (Grade B) in 44 percent of cases. Nearly half of the 110 patients who underwent surgery had a C3 incontinence before treatment. Positive results were achieved in 75 percent of cases after surgery: e.g., AI score significantly improved from 4.2 +/- 1.6 to 1.5 +/- 1.9 (P less than 0.001) in those with AI and rectal prolapse. Most of the failures were the patients with idiopathic C3 incontinence. In conclusion, this grading and scoring system allowed a satisfactory assessment of patients' AI before and after treatment. It may also be used to achieve an objective comparison between different series.

Entities:  

Mesh:

Year:  1992        PMID: 1568401     DOI: 10.1007/bf02049407

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  61 in total

1.  Transsacral rectopexy for recurrent complete rectal prolapse.

Authors:  Y Araki; H Isomoto; Y Tsuzi; A Matsumoto; M Yasunaga; K Yamauchi; K Hayashi; T Kodama
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

2.  Etiology and severity of symptoms of fecal incontinence: is there a correlation?

Authors:  F Boffi; S Ayabaca; A Corradi; C Renzi; M Pescatori
Journal:  Int J Colorectal Dis       Date:  2002-01       Impact factor: 2.571

3.  Comparative analysis of summary scoring systems in measuring fecal incontinence.

Authors:  Moo-Kyung Seong; Sung-Il Jung; Tae-Won Kim; Hee-Kyung Joh
Journal:  J Korean Surg Soc       Date:  2011-11-01

4.  Advancement flap in the management of chronic anal fissure: a prospective study.

Authors:  Rosalia Patti; Giovanni Guercio; Valentina Territo; Paolo Aiello; Giuseppe Livio Angelo; Gaetano Di Vita
Journal:  Updates Surg       Date:  2012-04-10

5.  Sphincteroplasty for fecal incontinence in the era of sacral nerve modulation.

Authors:  Donato F Altomare; Michele De Fazio; Ramona Tiziana Giuliani; Giorgio Catalano; Filippa Cuccia
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

6.  Outcome of overlapping anal sphincter repair after 3 months and after a mean of 80 months.

Authors:  Goran I Barisic; Zoran V Krivokapic; Velimir A Markovic; Milos A Popovic
Journal:  Int J Colorectal Dis       Date:  2005-04-14       Impact factor: 2.571

7.  Long-term manometric study of anal sphincter function after hemorrhoidectomy.

Authors:  Rosalia Patti; Piero Luigi Almasio; Matteo Arcara; Massimiliano Sparacello; Stefania Termine; Sebastiano Bonventre; Gaetano Di Vita
Journal:  Int J Colorectal Dis       Date:  2006-07-22       Impact factor: 2.571

8.  Is there a role for concomitant pelvic floor repair in patients with sphincter defects in the treatment of fecal incontinence?

Authors:  Scott R Steele; Patrick Lee; Philip S Mullenix; Matthew J Martin; Eugene S Sullivan
Journal:  Int J Colorectal Dis       Date:  2005-08-02       Impact factor: 2.571

9.  [Fecal incontinence].

Authors:  J Braun; S Willis
Journal:  Chirurg       Date:  2004-09       Impact factor: 0.955

10.  Idiopathic hypertensive anal canal: a place of internal sphincterotomy.

Authors:  Mohamed Farid; Ayman El Nakeeb; Mohamed Youssef; Waleed Omar; Elyamani Fouda; Tamer Youssef; Waleed Thabet; Hisham Abd Elmoneum; Wael Khafagy
Journal:  J Gastrointest Surg       Date:  2009-06-11       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.